Patients with alopecia areata have a significantly increased risk of developing psychiatric and autoimmune diseases both before and after diagnosis, highlighting the importance of comprehensive care ...

Come together to increase awareness, provide help for today and hope for tomorrow for millions living with alopecia areata.

Alopecia areata is more prevalent in patients with IBD, especially those on anti-TNF therapy, compared with controls. The study found no significant difference in alopecia improvement between those ...

5 Things to Avoid When You Have Alopecia Areata Alopecia areata is an autoimmune disease in which the body attacks the hair follicles. If you’re one of the 6.8 million people in the U.S. with this ...

PARIS — Two investigational oral Janus kinase (JAK) inhibitors are safe and effective for patients with moderate to severe hair loss, according to 24-week interim findings from a randomized, ...

The researchers found that patients perceived alopecia areata as chronic and life-impacting, with 81% reporting anxiety or depressive symptoms. HealthDay News — Alopecia areata (AA) has a severe ...

Dr. Samantha Venkatesh from Rush University Medical Center explains alopecia areata—an autoimmune condition affecting 7 ...

Denise Jackson, an alopecia areata support group leader from Yountville, was recently a featured guest on Fox TV/KTVU's Bay Area People. Jackson discussed her experience with the disease, alopecia ...

Alopecia areata is a prevalent autoimmune condition marked by non-scarring hair loss, affecting nearly 2% of the population during their lifetime. The condition involves the breakdown of the immune ...

Fatty liver disease is linked to hair health. The liver metabolizes nutrients vital for hair. Liver dysfunction can cause ...

Alopecia areata, which causes hair loss, won't stop Miss America contestant. Jan. 5, 2011— -- Kayla Martell, crowned Miss Delaware in June, will have to prove she has the confidence and poise to ...

Patients with alopecia areata (AA) had a higher prevalence of several psychiatric and autoimmune comorbidities at baseline and were at greater risk of developing those comorbidities after diagnosis.